Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Trial

Initial Treatment With Golimumab in Early PsA

NCT01871649 ·Status: COMPLETED ·Phase: PHASE3

A Safety and Efficacy Study of Golimumab (CNTO148) in Patients With Active Rheumatoid Arthritis (RA)

NCT00771251 ·Status: COMPLETED ·Phase: PHASE3

A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis

NCT03733925 ·Status: COMPLETED ·Phase: PHASE4

Evaluate the Preliminary Efficacy, Safety, and PK of Subcutaneous JS005 in Chinese Adult Patients With Active AS

NCT05212051 ·Status: UNKNOWN ·Phase: PHASE2

GOLimumab and Methotrexate Versus Methotrexate in Very Early PsA

NCT04108468 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing Spondylitis

NCT00265083 ·Status: COMPLETED ·Phase: PHASE3

Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (GO-BACK) (MK-8259-038)

NCT03253796 ·Status: COMPLETED ·Phase: PHASE4

Evaluate the Preliminary Efficacy, Safety, and PK of Subcutaneous JS005 in Chinese Adult Patients With Active Nr-axSpA

NCT05242588 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, in MTX naïve Psoriatic Arthritis Patients

NCT02065713 ·Status: COMPLETED ·Phase: PHASE3

Effect of Anti-TNF (Alpha) Treatment on Vascular Stiffness in Ankylosing Spondylitis (AS)

NCT01212653 ·Status: COMPLETED ·Phase: PHASE4

A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)

NCT00299546 ·Status: COMPLETED ·Phase: PHASE3

to Evaluate the Preliminary Efficacy and Safety of GR1501 Injection in Patients With Active Axial Spondyloarthritis

NCT05162937 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate 608 in Patients with Ankylosing Spondylitis (AS)

NCT06242652 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Evaluate the Safety and Tolerability of Multiple Doses of Gerilimzumab in Rheumatoid Arthritis Patients

NCT04179513 ·Status: UNKNOWN ·Phase: PHASE1

Subcutaneous Golimumab (GLM) Plus DMARDs for Rheumatoid Arthritis, Followed by Intravenous/Subcutaneous GLM Strategy (P06129 AM2)

NCT00975130 ·Status: COMPLETED ·Phase: PHASE3

Effects of Nonsteroidal Anti-Inflammatory Drugs in Recurrence of Spondyloarthritis Patients After Remission

NCT03425812 ·Status: RECRUITING ·Phase: NA

The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012)

NCT01668004 ·Status: COMPLETED ·Phase: PHASE4

A Study of Mavrilimumab Versus Anti Tumor Necrosis Factor in Subjects With Rheumatoid Arthritis

NCT01715896 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNFα Naive Participants With Active Radiographic Axial Spondyloarthritis

NCT02437162 ·Status: TERMINATED ·Phase: PHASE3

Exploration of TNF-alpha Blockade With Golimumab in the Induction of Clinical Remission in Patients With Early Peripheral Spondyloarthritis (SpA) According to ASAS-criteria

NCT01426815 ·Status: COMPLETED ·Phase: PHASE3

Novel MRI ANd Biomarkers in GOlimumab-treated Patients With Axial Spondyloarthritis

NCT02011386 ·Status: COMPLETED

Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA)

NCT00048542 ·Status: COMPLETED ·Phase: PHASE3

Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1)

NCT00844805 ·Status: COMPLETED ·Phase: PHASE3

Phase Ⅰ Clinical Trial of Gerilimzumab Injection in Healthy Subjects

NCT04178070 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Evaluate 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)

NCT06222671 ·Status: RECRUITING ·Phase: PHASE2